DMYDY

Diamyd Medical AB

 
Sponsored ADR (1 ADS : 1 Ordinary)
PAL: BNY Mellon OTCQX International

OTC Disclosure & News Service

Release Date Title Type
May 22, 2012 Diamyd Medical's Phase II study in cancer pain fully recruited Press Release
Feb 02, 2012 Diamyd Medical's Phase III study published in the New England Journal of Medicine Press Release
Jan 09, 2012 Prevention study with Diamyd´s diabetes vaccine fully recruited Press Release
Dec 07, 2011 Bulletin from Annual General Meeting: Diamyd Medical towards new goals Press Release
Nov 17, 2011 University of Florida Research Foundation and Diamyd Medical settle lawsuit Press Release
Nov 07, 2011 Information about Summons to the Annual General Meeting of Diamyd Medical AB Press Release
Sep 12, 2011 Diamyd awarded three million dollar grant and expands the NTTDS portfolio Press Release
Aug 17, 2011 Diamyd puts focus on pain projects and reduces costs Press Release
Jul 04, 2011 Diamyd appoints Peter Zerhouni as President Press Release
Jun 30, 2011 Diamyd increases shareholding in Protein Sciences Corporation Press Release
Jun 28, 2011 Diamyd presents detailed results of European Phase III study Press Release
Jun 28, 2011 TrialNet presents results from a study with Diamyd® Press Release
Jun 23, 2011 Diamyd initiates closure of US Phase III study Press Release
Jun 01, 2011 Diamyd regains control of diabetes therapy Press Release
May 09, 2011 Diamyd reports initial results from European Phase III trial in patients newly diagnosed with type 1 diabetes Press Release
Apr 26, 2011 Diamyd Replaces CEO Press Release
Apr 21, 2011 Peter Zerhouni has been appointed Executive Vice President of Diamyd Medical AB Press Release
Apr 11, 2011 Diamyd results from Phase I clinical trial in cancer pain published in Annals of Neurology Press Release
Feb 28, 2011 Publication of change in the total number of shares and votes in Diamyd Medical AB Press Release
Feb 28, 2011 Publication of change in the total number of shares and votes in Diamyd Medical AB Press Release